oa Solvent-free Synthesis, Characterization, and Antimicrobial Evaluation of Ethyl 7-Phenyl-5-Propyl-4,7-dihydro- [1, 2, 4]triazolo[1,5-a]pyrimidine-6-carboxylate Derivatives

References

1. EbenezerO. JordaanM.A. CarenaG. BonoT. ShapiM. TuszynskiJ.A. An overview of the biological evaluation of selected nitrogen-containing heterocycle medicinal chemistry compounds.Int. J. Mol. Sci.20222315811710.3390/ijms23158117 35897691
   [Google Scholar]
2. Abu-HashemA.A. Al-HussainS.A. Synthesis and biological activities of new heterocyclic compounds with antimicrobial properties.Pharmaceuticals20241712163210.3390/ph17121632 39770474
   [Google Scholar]
3. FelicettiT. MarcouG. HorvathD. VarnekA. Applications of machine learning in medicinal chemistry: Current status and future directions.Curr. Med. Chem.20222981379140710.2174/0929867328666210526120534 34042030
   [Google Scholar]
4. RomagnoliR. BaraldiP.G. FruttaroloF. PretiD. Development of new anticancer agents targeting tubulin.Pharmaceuticals2022158103110.3390/ph15081031 36015179
   [Google Scholar]
5. ManzoorS. AhmadM. FarooqU. KhanM.S. RehmanM.T. Molecular docking and synthesis of new thiazole derivatives with antibacterial activity.Pharm. Res.202340116718510.1007/s11095‑022‑03429‑1 36376607
   [Google Scholar]
6. DasS.K. SinghR. GhoshT. RayS. Design and development of fused heterocyclic scaffolds for potential anticancer agents.Pharm. Chem. J.202357677779210.1007/s11094‑023‑02952‑8
   [Google Scholar]
7. ElshobaryM.E. HegazyG.H. AlharbiM. Al-SaneaM.M. Synthesis and biological evaluation of new benzimidazole-based molecules as anticancer agents.Pharmaceuticals202518340210.3390/ph18030402 40143178
   [Google Scholar]
8. RahmanS.M.A. AlamM.S. HossenM.J. FaruqueeH.M. Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds.Eur. J. Med. Chem.202325911569910.1016/j.ejmech.2023.115699
   [Google Scholar]
9. AliwainiS. TahaM. IsmailI.S. AhmadR. ImranS. Synthesis of new imidazole derivatives with potent antifungal activity.Molecules20212613406510.3390/molecules26134065 34279406
   [Google Scholar]
10. AlnajjarR. MohamedN. KawafiN. Bicyclo[1.1.1]Pentane as phenyl substituent in atorvastatin drug to improve physicochemical properties: Drug-likeness, DFT, pharmacokinetics, docking, and molecular dynamic simulation.J. Mol. Struct.2021123012962810.1016/j.molstruc.2020.129628
    [Google Scholar]
11. ZafarW. AshfaqM. SumrraS.H. A review on the antimicrobial assessment of triazole-azomethine functionalized frameworks incorporating transition metals.J. Mol. Struct.2023128813574410.1016/j.molstruc.2023.135744
    [Google Scholar]
12. SilvaD.P.D. CardosoM.S. MacedoA.J. Endophytic fungi as a source of antibacterial compounds— A focus on Gram-negative bacteria.Antibiotics (Basel)20221111150910.3390/antibiotics11111509 36358164
    [Google Scholar]
13. CLSI Performance standards for antimicrobial susceptibility testing.2023https://clsi.org/shop/standards/m100/
    [Google Scholar]
14. HossainT.J. Evaluation of novel antimicrobial agents from natural sources against resistant strains.Eur. J. Microbiol. Immunol. (Bp.)20241429711510.1556/1886.2024.00035 38648108
    [Google Scholar]
15. Sheldon, R.A. The E factor: Fifteen years on.Green Chem.2017191184310.1039/B713736M
    [Google Scholar]
16. LivermoreD.M. Has the era of untreatable infections arrived?Clin. Infect. Dis.202173Suppl. 4S255S26210.1093/jac/dkp255
    [Google Scholar]
17. StevensD.L. BisnoA.L. ChambersH.F. DellingerE.P. GoldsteinE.J.C. GorbachS.L. HirschmannJ.V. KaplanS.L. MontoyaJ.G. WadeJ.C. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.Clin. Infect. Dis.201459214715910.1093/cid/ciu444 24947530
    [Google Scholar]
18. PappasP.G. KauffmanC.A. AndesD.R. ClancyC.J. MarrK.A. Ostrosky-ZeichnerL. ReboliA.C. SchusterM.G. VazquezJ.A. WalshT.J. ZaoutisT.E. SobelJ.D. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.Clin. Infect. Dis.2016624e1e5010.1093/cid/civ933 26679628
    [Google Scholar]
19. WalshT.J. DixonD.M. ChandrasekarP. EpsteinJ. MartyF.M. PappasP.G. Overview: Emerging fungal infections and their treatment.Clin. Microbiol. Rev.2019323e00029e18
    [Google Scholar]
20. AnastasP.T. WarnerJ.C. Green Chemistry: Theory and Practice.New York, NY, USAOxford University Press1998
    [Google Scholar]
21. VentolaC.L. The antibiotic resistance crisis: Part 1: causes and threats.P&T2015404277283 25859123
    [Google Scholar]
22. RajakumariK. AravindK. BalamugundhanM. JagadeesanM. SomasundaramA. Brindha DeviP. RamasamyP. Comprehensive review of DNA gyrase as enzymatic target for drug discovery and development.Eur. J. Med. Chem. Rep.20241210023310.1016/j.ejmcr.2024.100233
    [Google Scholar]
23. AbdelkhalekA.S. AttiaM.S. KamalM.A. Triazolopyrimidine derivatives: An updated review on recent advances in synthesis, biological activities and drug delivery aspects.Curr. Med. Chem.202431141896191910.2174/0929867330666230228120416 36852819
    [Google Scholar]
24. KumawatJ. JainS. MisraN. JainP. KishoreD. PatelS. Ecofriendly synthesis, structural insights, and antimicrobial potential of 1,3,5-tri-N-substituted hexahydro-1,3,5-triazine derivatives.Anal. Chem. Lett.202515236338510.1080/22297928.2025.2475133
    [Google Scholar]